ROBIN HOWARD W (President & CEO) sold 3.9% of their position (2.21K shares) of NEKTAR THERAPEUTICS on the open market
Open‑market sale worth $119.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/25/2025ACC: 0001193125-25-297850
DirectorOfficer· President & CEO
Since Aug 2018
+17.07K
Net shares
Net buyer
$119.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
19.28K acquired · 2.21K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+7.11K
Price / share
—
Trade value
—
% of position
14.4%
11/21/2025
49.34K→56.45K
Common Stock
Direct
Shares
−2.21K
Price / share
$54.28
Trade value
$119.80K
% of position
3.9%
11/25/2025
56.45K→54.24K
Total
Net shares
+4.90K
Net value
-$119.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/21/2025 | A · Award | +7.11K | — | — | 14.4% | 49.34K | 56.45K |
| Common Stock Direct | 11/25/2025 | S · Sale | −2.21K | $54.28 | $119.80K | 3.9% | 56.45K | 54.24K |
| Total | +4.90K | -$119.80K | ||||||
Derivative Transactions1
Stock Option
Direct
Converts to
Common Stock
12.17K shares
Shares
+12.17K
Strike price
281.25
Held after
12.17K
Exercisable
—
11/21/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock12.17K shares | 11/21/2025 | A · Award | +12.17K | 281.25 | — | 12.17K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned28.00
Total
28.00 indirect28.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 28.00 | Indirect |
| Total | 28.00 | 28.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported